MOTS-c: the peptide your mitochondria write when you exercise.

For most of the twentieth century, biology textbooks described mitochondria as the cell's power plants — efficient, slightly alien organelles with their own loop of DNA, busy turning oxygen and glucose into ATP. The textbooks were not wrong. They were incomplete. Over the last fifteen years, the mitochondrion has been re-cast as something more interesting: a signaling hub that talks back to the rest of the cell, and beyond it, to the rest of the body. The molecules carrying those messages are short peptides encoded directly inside mitochondrial DNA. MOTS-c, sixteen amino acids long, is the second one we found.

How a peptide hides inside ribosomal RNA

Mitochondrial DNA was meant to be exhausted territory. The circular 16,569-base-pair genome had been sequenced in 1981, its 13 protein-coding genes annotated, its tRNAs and ribosomal RNAs charted. Then, in 2015, Changhan Lee and colleagues at the University of Southern California published a paper in Cell Metabolism that re-read part of that map. Inside the gene for the 12S ribosomal RNA, they identified a short open reading frame nobody had translated. Its product was a 16-residue peptide. They named it MOTS-c, for mitochondrial open reading frame of the 12S rRNA, type c.

What the USC group found was striking. MOTS-c circulates in blood. It moves into skeletal muscle. There it inhibits the folate cycle, throttles back de novo purine biosynthesis, raises the AMP-to-ATP ratio, and activates AMP-activated protein kinase (AMPK) — the master energy sensor that fires every time you walk uphill or skip a meal. Mice given exogenous MOTS-c resisted both age-related and high-fat-diet-induced insulin resistance and gained less weight on the same chow.

What endurance training looks like inside a Shanghai laboratory

If MOTS-c mimics exercise, does exercise produce more MOTS-c? A 2024 paper from Rengfei Shi's group at Shanghai University of Sport, published in Free Radical Biology and Medicine, asked exactly that. The researchers compared serum MOTS-c in marathon runners against sedentary controls, then validated their findings in a long-term endurance training mouse model. Circulating MOTS-c tracked closely with VO2 max. Endurance-trained mice secreted more of the peptide, and their skeletal muscle mitochondria responded with higher respiratory capacity through the AMPK/PGC-1α pathway.

The Shanghai data are correlational, but they suggest a closing loop: exercise stresses the mitochondrion, the mitochondrion secretes MOTS-c, MOTS-c amplifies the same metabolic adaptations exercise was demanding in the first place. A separate 2024 paper from Iran's Shahid Chamran University, in Diabetes Research and Clinical Practice, showed something more surgical: in diabetic sand rats, eight weeks of moderate-intensity interval training raised muscle MOTS-c more than high-intensity training did, and the moderate group was the one with better insulin sensitivity. Dose, in other words, is not a synonym for benefit.

Beyond the obvious: a peptide that helps cells patch their own holes

In August 2024, a group at the Fourth Military Medical University in Xi'an published work in Theranostics describing a function nobody had predicted: membrane repair. When a muscle fiber tears under load — eccentric exercise, ischemia-reperfusion injury, muscular dystrophy — the cell calls a protein called TRIM72 to the wound site. TRIM72 trafficking, it turns out, depends on MOTS-c. The peptide binds TRIM72's C-terminus and shepherds it to the damaged membrane. In TRIM72-knockout mice, MOTS-c still helped vesicles fuse with the wound by interacting directly with phosphatidylinositol (4,5)-bisphosphate in the membrane lipid layer.

The same group ran cardiac ischemia-reperfusion experiments. MOTS-c pretreatment blunted the membrane damage that follows reperfusion and preserved heart function. This is no longer just a metabolic peptide. It is structural medicine.

MOTS-c may be the first known molecule encoded by mitochondria that travels outside them to coordinate the rest of the body's energy economy. Whether it stays the only one is a different question.

A 2025 paper that ties it together

In May 2025, a group at Chengdu Sport University in Sichuan published in Scientific Reports a study that knit metabolism and tissue repair together. Type 2 diabetic rats develop liver fibrosis. Both aerobic exercise and exogenous MOTS-c slowed the fibrosis and, in combination, did better than either alone. The mechanism converged on the Keap1-Nrf2 antioxidant axis upstream of TGF-β/Smad — the canonical fibrosis pathway.

Often studied alongside

MOTS-c rarely appears alone in longevity protocols. Adjacent research has paired it with NAD+ precursors — a logical pairing given that AMPK activation downstream of MOTS-c and SIRT1 activation downstream of NAD+ converge on shared mitochondrial biogenesis programs. Epitalon, the four-amino-acid peptide associated with telomerase upregulation work from the St. Petersburg Institute of Bioregulation and Gerontology, shows up in the same protocols, though direct interaction studies between MOTS-c and Epitalon are scarce.

Practical considerations

MOTS-c is sold for research use only. Storage: lyophilized at −20°C; reconstituted in bacteriostatic water and refrigerated for short-term use. Half-life in circulation, in rodent models, is short — minutes — which is why most research protocols use daily subcutaneous administration.